S. Lai

Novel Plasma Proteomic Biomarkers for Early Identification of Induction Chemotherapy Beneficiaries in Locoregionally Advanced Nasopharyngeal Carcinoma

Jun Liu, Wen-jie Dai, Jicheng Li, 2022, Frontiers in Oncology.

INTENSITY-MODULATED RADIOTHERAPY VERSUS CONVENTIONAL TWO-DIMENSIONAL RADIOTHERAPY INFLUENCE THE TREATMENT RESULTS IN NASOPHARYNGEAL CARCINOMA PATIENTS ?

Li-Zhi Liu, Jun Ma, A. Lin, 2011 .

10-Year Results of Therapeutic Ratio by Intensity-Modulated Radiotherapy Versus Two-Dimensional Radiotherapy in Patients with Nasopharyngeal Carcinoma.

Li-Zhi Liu, Jun Ma, A. Lin, 2018, The oncologist.

Re-evaluation of 6th edition of AJCC staging system for nasopharyngeal carcinoma and proposed improvement based on magnetic resonance imaging.

Ying Sun, Y. Mao, Li Li, 2009, International journal of radiation oncology, biology, physics.

Radiotherapy opens the blood-brain barrier and synergizes with anlotinib in treating glioblastoma.

Yamei Chen, Jian-guo Feng, Ye Tian, 2023, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Upfront Cranial Radiotherapy vs. EGFR Tyrosine Kinase Inhibitors Alone for the Treatment of Brain Metastases From Non-small-cell Lung Cancer: A Meta-Analysis of 1465 Patients

M. Deng, Xiao-jing Du, Shao-xiong Wu, 2018, Front. Oncol..

How does intensity-modulated radiotherapy versus conventional two-dimensional radiotherapy influence the treatment results in nasopharyngeal carcinoma patients?

Li-Zhi Liu, Jun Ma, A. Lin, 2011, International journal of radiation oncology, biology, physics.